Navigation Links
Cancer: The cost of being smarter than chimps?
Date:6/10/2009

Are the cognitively superior brains of humans, in part, responsible for our higher rates of cancer? That's a question that has nagged at John McDonald, chair of Georgia Tech's School of Biology and chief research scientist at the Ovarian Cancer Institute, for a while. Now, after an initial study, it seems that McDonald is on to something. The new study is available online in the journal Medical Hypothesis and will appear in the forthcoming issue of the journal.

"I was always intrigued by the fact that chimpanzees appear to have lower rates of cancer than humans," said McDonald. "So we went back and reanalyzed some previously reported gene expression studies including data that were not used in the original analyses."

McDonald and his graduate students, Gaurav Arora and Nalini Polivarapu, compared chimp-human gene expression patterns in five tissues: brain, testes, liver, kidneys and heart. They found distinct differences in the way apoptosis or programmed cell death operates, suggesting that humans do not "self-destroy" cells as effectively as chimpanzees do. Apoptosis is one of the primary mechanisms by which our bodies destroy cancer cells.

"The results from our analysis suggest that humans aren't as efficient as chimpanzees in carrying out programmed cell death. We believe this difference may have evolved as a way to increase brain size and associated cognitive ability in humans, but the cost could be an increased propensity for cancer," said McDonald.

Like all evolutionary hypotheses, this can't be proven absolutely, according to McDonald. However, his lab has recently obtained additional direct experimental evidence consistent with the hypothesis that apoptotic function is more efficient in chimps than in humans.


'/>"/>

Contact: David Terraso
david.terraso@comm.gatech.edu
404-385-2966
Georgia Institute of Technology
Source:Eurekalert  

Page: 1

Related biology news :

1. From cars to cancer: UH professor employs auto industry tools for tumor therapy
2. Early detection of lung cancer: New data presented at multidisciplinary meeting
3. Cancer: Another step towards medication
4. Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors
5. Hispanic women and breast cancer: An understudied group
6. Stem cells and cancer: cancer pathways that also control the adult stem cell population
7. Scientists discover how cigarette smoke causes cancer: Study points to new treatments, safer tobacco
8. Prostate cancer: Watchful wait or vaccinate?
9. DNA-Prokids: Genetic identification against traffic in human beings
10. The importance of being helpful -- Cooperative cichlids boost their own reproductive success
11. Promising new drug being evaluated as possible treatment option for fragile X syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer: The cost of being smarter than chimps?
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at this ... leader in connected health and biometric measurement devices and services, will be ... On display in A&D Medical,s special CES Exhibit Suite , ... ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which ... it has submitted a 510(k) to the FDA, requesting clearance of the MyoCycle ... electrical stimulation (FES) technology. , The submission marks a major milestone for ...
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev ... Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join ... clinical research issues such as trial performance metrics, patient enrollment diversity, protocol optimization, ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... report the publishing of the latest paper by its Science Editor, Dr. Elisabeth ... (Nederlands Tijdschrift voor Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from ...
(Date:1/18/2017)... Jan. 18, 2017 Shareholder rights law firm ... whether the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... connection with the proposed sale of the Company to ... that develops small molecules for the acute treatment of ... it had signed a definitive merger agreement with Eli ...
Breaking Biology Technology: